SUMMARY
PharmEasy’s existing investors 360 ONE and Ranjan Pai’s Claypond Capital have obtained the CCI’s nod to jointly purchase additional stake in the healthtech unicorn
Following PharmEasy’s $216 Mn funding round last year, Ranjan Pai held an estimated 12% stake in the digital pharmacy
This comes at a time when PharmEasy is grappling with funding crunch, valuation markdowns and uncertainty over its IPO
The Competition Commission of India (CCI) has approved the proposals of 360 ONE and Claypond Capital to jointly…
